🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic presentation by Monika Masanam, MD on MIBC after NST! Our retrospective institutional analysis shows LR <2% at 3 years of follow up suggesting this approach is safe in well selected patients #SSO2025 Brigham and Women’s Department of Surgery Mass General Surgery Dana-Farber’s Breast Oncology Center Tari King MD Dr. E Mittendorf

Bittersweet for this to be the last #SSO with my mentor Mark S. Talamonti MD who recently announced his retirement Endeavor Health UChicago Surgery - congratulations!! 🎊 and thank you for helping me get where I am today ❤️ #SSO2025 Society of Surgical Oncology

Successful and fun #SSO2025 with our trainees and team Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center ! Tari King MD Dr. E Mittendorf Laura Dominici MD Monika Masanam, MD Eliza Hersh Lorentzen, MD

Genomic assays have transformed breast cancer care—but they’re not the full story. Our review JAMA Oncology shows that racial gaps in outcomes persist, even after accounting for molecular features —urging a more holistic approach to precision medicine. #bcsm UNC Lineberger

Excited to be in Korea for #GBCC2025! Amazing hospitality and a well organized high quality meeting are my first impressions!

Standing room only for Ann Partridge MD, MPH plenary talk on young women with breast cancer at #GBCC2025 Dana-Farber’s Breast Oncology Center

Newly Updated ASCO Guideline on Sentinel Lymph Node Biopsy in Early-Stage #BreastCancer, read the full set of recommendations here: 🔓pubmed.ncbi.nlm.nih.gov/40209128/ ✍️Dr.Clara Park, MD, FACS Alison conlin Lynn T. Dengel Brittany Harvey Alastair M Thompson Mylin Torres in Journal of Clinical Oncology

Kicking off the #ASBrS2025 scientific sessions with Christopher Vetter, MD, MSc presenting on validation of a novel de novo metastatic breast cancer - model stratified outcomes well with some shifts with modified definitions Judy Boughey Mayo Clinic Jennifer Plichta MD (she/her)

Loved this wonderful presentation (by a med student nonetheless!) showing that ASBrS gets more oral publications to publication than any other society - kudos to the hard work of the behind the scenes scientific program and publications committees! Sarah L. Blair

Excellent great debate on observation for DCIS at #ASBrS2025 with DCIS giants Shelley Hwang and Dr. Kimberly Van Zee - gloves 🥊 we’re definitely out! ASBrS

Great talk by Laura Dominici MD pulling together the data after a pro/con debate on contralateral prophylactic mastectomy. Very thoughtful and practical way to think about how to best frame discussion with patients #ASBrS2025 Tari King MD Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center

Excellent and thought provoking talk on the ethics of shared decision making in breast surgery from Puneet Singh, MD FACS at #ASBrS2025 MD Anderson Cancer Center ASBrS - providing an ethical framework to consider in these discussions

Brilliant study by Shayna Showalter UVA Surgery. POWER trial of 90-day PRE-op 🔪endocrine therapy 💊 to assess tolerance before decision re: RT omission. Early improved endocrine compliance. ASBrS #ASBrS2025 POWER2 enrolling! 🎉

Fantastic presentation on our surgeon led DCIS program by Monika Masanam, MD - ET uptake was similar when prescribing shifted from med onc to surg onc, with a lot of enthusiasm for low dose tamoxifen in recent years #ASBrS2025 ASBrS Tari King MD Dr. E Mittendorf Dana-Farber’s Breast Oncology Center

Excellent presentation by Dr. Amanda Nash 🤩🤩🤩 Margin width and local recurrence following #mastectomy for #DCIS. Local recurrence is low wt 1.9%. Factors other than MARGIN is likely contribute to IBTR ⁦Amanda Nash⁩ ⁦Shelley Hwang⁩ #ASBrS2025

Incredible presidential address by our inspiring ASBrS president Judy Boughey on her path through practical changing clinical trials she’s led and lessons learned along the way 🤩 #ASBrS2025 Mayo Clinic Take aways: get involved, ask good questions, timing is key

Fun night at the ASBrS gala catching up with prior fellows Mass General Surgery Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center & celebrating a great meeting and presidential year! #ASBrS2025

Always learn so much from Tari King MD speaking so eloquently about atypia and LCIS ASBrS #ASBrS2025 Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center

New JAMA Oncology review on Prognostic and Predictive Insights From Genomic Assays for #BreastCancer in Diverse Populations, check it out here: pubmed.ncbi.nlm.nih.gov/40178824/ Yara Abdou, MD, MSCR Olga Kantor MD, MS, FACS Jennifer Racz Lori Pierce Eric Winer, MD

Don't miss the #ASCO25 Rapid Oral Abstract Session on Saturday morning on Care Delivery and Models of Care to see a presentation on #BreastCancer diagnosis, management, and outcomes in transgender, nonbinary, and gender-diverse individuals. Olga Kantor MD, MS, FACS Chandler S Cortina, MD